Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline + vonoprazan dual therapy vs amoxicillin + vonoprazan for Helicobacter pylori eradication
ChiCTR2500099105Phase 4Not yet recruiting
- Sponsor
- Second Hospital of Lanzhou University
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Helicobacter pylori infection comparing vonoprazan + minocycline with vonoprazan + amoxicillin (2 arms). Primary endpoint: Comparison of Helicobacter pylori eradication rate. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
vonoprazanminocyclineamoxicillin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2500099105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500099105.